ロード中...
Termination of Bleeding by a Specific, Anti-catalytic Antibody to Plasmin
BACKGROUND: Excessive, plasmin-mediated fibrinolysis augments bleeding and contributes to death in some patients. Current therapies for fibrinolytic bleeding are limited by modest efficacy, low potency and off-target effects. OBJECTIVES: To determine whether an antibody directed against unique loop...
保存先:
| 出版年: | J Thromb Haemost |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359864/ https://ncbi.nlm.nih.gov/pubmed/31136076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14522 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|